O'Shaughnessy Asset Management
ACHN

O'Shaughnessy Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,602
Closed -$10K – 2022
2019
Q4 		$10K Buy
+1,602
New +$9.27K ﹤0.01% 1315

O'Shaughnessy Asset Management's ACHN Position: Q1 2020 in Review

O'Shaughnessy Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 1,602 shares — an estimated $10K sold.

O'Shaughnessy Asset Management first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $10K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • O'Shaughnessy Asset Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,602 Achillion Pharmaceuticals shares in Q1 2020, an estimated $10K.
  • O'Shaughnessy Asset Management first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • O'Shaughnessy Asset Management's Achillion Pharmaceuticals position peaked at $10K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2020, filed 13 May 2020.